It is overexpressed in various cancers, such as lung cancer, colon cancer, multiple myeloma, etc., and is closely associated with poor prognosis.90,91 Therefore, targeting McL-1 is a promising therapeutic strategy for cancer. This evidence concerns the gene MCL1 and lung cancer.